search
Sofinnova Partners
Trends
- 1Sofinnova closes oversubscribed €82 million MedTech startup fund●Sofinnova Partners closes oversubscribed €82 million MD Start IV fund to build new MedTech startups
Sofinnova Partners, the Paris-based venture capital firm, has closed its MD Start IV fund at €82 million, exceeding its original target. The fund will be used to found and back new MedTech startups, following Sofinnova's model of building companies from scratch alongside inventors and clinicians. The oversubscribed close signals continued investor appetite for early-stage medical technology despite a tougher funding climate.